Variety Formulations Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 23-06-2024
- Paid Up Capital ₹ 1.76 M
as on 23-06-2024
- Company Age 36 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.93 Cr
as on 23-06-2024
- Satisfied Charges ₹ 2.57 M
as on 23-06-2024
- Revenue -29.38%
(FY 2022)
- Profit -51.77%
(FY 2022)
- Ebitda 30.21%
(FY 2022)
- Net Worth 2.80%
(FY 2022)
- Total Assets -2.35%
(FY 2022)
About Variety Formulations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.76 M.
The company currently has active open charges totaling ₹1.93 Cr. The company has closed loans amounting to ₹2.57 M, as per Ministry of Corporate Affairs (MCA) records.
Thekka Balakrishnan and David Palayoor serve as directors at the Company.
- CIN/LLPIN
U24231KL1988PTC005228
- Company No.
005228
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Nov 1988
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Palakkad, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Variety Formulations?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
David Palayoor  | Managing Director | 30-Jun-2010 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Thekka Balakrishnan | Director | 28-Sep-1999 | Current |
Financial Performance of Variety Formulations.
Variety Formulations Pvt Ltd, for the financial year ended 2022, experienced significant reduction in revenue, with a 29.38% decrease. The company also saw a substantial fall in profitability, with a 51.77% decrease in profit. The company's net worth moved up by a moderate rise of 2.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Variety Formulations?
In 2018, Variety Formulations had a promoter holding of 96.59% and a public holding of 3.41%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Dhanlaxmi Bank Limited Creation Date: 25 Mar 2019 | ₹1.62 Cr | Open |
Dhanlaxmi Bank Limited Creation Date: 06 Sep 2013 | ₹3.07 M | Open |
The Catholic Syrian Bank Ltd Creation Date: 02 Jun 2008 | ₹1.00 M | Satisfied |
How Many Employees Work at Variety Formulations?
Variety Formulations has a workforce of 1 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Variety Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Variety Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
